Drug Type Therapeutic radiopharmaceuticals |
Synonyms |
Target |
Mechanism P2X7 receptor antagonists(P2X purinoceptor 7 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H14ClF3N2O2 |
InChIKeyBJEMSIVBBUBXMZ-FXKBKNDVSA-N |
CAS Registry1695551-20-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuroinflammation | Preclinical | US | 01 May 2015 |